Keck Medical Center of USC Pasadena
Pasadena, California, United States
Surgical center in Pasadena, California
625 S Fair Oaks Ave Ste 400, Pasadena, CA 91105
About Keck Medical Center of USC Pasadena
"Expert physicians offering a variety of treatments and services for a broad range of medical conditions."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
36
SWOG Cancer Research Network
10
Alliance for Clinical Trials in Oncology
8
Pfizer
6
NRG Oncology
4
ECOG-ACRIN Cancer Research Group
3
University of Southern California
2
Gynecologic Oncology Group
1
Clinical Trials at Keck Medical Center of USC Pasadena
During the past decade, Keck Medical Center of USC Pasadena conducted 57 clinical trials. In the 10-year time frame, 57 clinical trials started and 19 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 15 clinical trials were completed. i.e. 150%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
2009-07-15
2021-06-15
Completed
506
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
2009-07-15
2022-02-08
Completed
1,333
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
2011-01-15
2024-03-07
Active, not recruiting
5,083
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
2012-06-12
2023-06-30
Active, not recruiting
1,194
S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer
2013-03-06
2027-10-01
Active, not recruiting
1,313
Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer
2014-03-17
2023-09-13
Active, not recruiting
469
Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
2015-01-12
2023-09-02
Active, not recruiting
57
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Keck Medical Center of USC Pasadena" #1 sponsor was "National Cancer Institute (NCI)" with 36 trials, followed by "SWOG Cancer Research Network" with 10 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "Pfizer" with 6 trials sponsored and "NRG Oncology"
with 6 trials sponsored. Other sponsors include 1 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Keck Medical Center of USC Pasadena"
#1 collaborator was "National Cancer Institute (NCI)" with 28 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were
collaborators in the rest 15 trials.
Clinical Trials Conditions at Keck Medical Center of USC Pasadena
According to Clinical.Site data, the most researched conditions in "Keck Medical Center of USC Pasadena" are
"Invasive Breast Carcinoma" (5 trials), "Stage IV Bladder Urothelial Carcinoma AJCC v7" (5 trials), "Metastatic Ureter Urothelial Carcinoma" (4 trials), "Stage III Bladder Urothelial Carcinoma AJCC v6 and v7" (4 trials) and "Metastatic Bladder Urothelial Carcinoma" (3 trials). Many other conditions were trialed in "Keck Medical Center of USC Pasadena" in a lesser frequency.
Clinical Trials Intervention Types at Keck Medical Center of USC Pasadena
Most popular intervention types in "Keck Medical Center of USC Pasadena" are "Drug" (53 trials), "Other" (36 trials), "Biological" (23 trials), "Procedure" (20 trials) and "Radiation" (4 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (21 trials), "Biospecimen Collection" (12 trials), "Computed Tomography" (11 trials), "Quality-of-Life Assessment" (10 trials) and "Questionnaire Administration" (8 trials). Other intervention names were less common.
Clinical Trials Genders at Keck Medical Center of USC Pasadena
The vast majority of trials in "Keck Medical Center of USC Pasadena" are
60 trials for "All" genders, 7 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at Keck Medical Center of USC Pasadena
Currently, there are NaN active trials in "Keck Medical Center of USC Pasadena".
undefined are not yet recruiting,
25 are recruiting,
27 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Keck Medical Center of USC Pasadena,
4 suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Keck Medical Center of USC Pasadena, 12 "Phase 1"
clinical trials were conducted, 35 "Phase 2" clinical
trials and 23 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".